All the highlights from STAT’s Breakthrough Summit East

• by Theresa Gaffney

• March 20, 2026

Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment

• by Jiayan Xu, Fei Qu, Xiaoyu Wang, Shuang Liang, Dongying Jiang, Zhenghua Wang

• April 29, 2026

AI Tool Could Speed Discovery of New Cancer Drug Targets

Many cancer therapies work by docking into specific “binding pockets” on the surface of proteins that are driving the disease. Scientists are continually searching for new binding sites for future cancer drugs, but this process can be slow and cumbersome.

• by

• April 30, 2026

• 5 min

Inequities in the Presentation of Disease and the Start of Treatment for De Novo Metastatic Breast Cancer

• by Jincong Q. Freeman, Apoorva Ravichandran, Sarah Poland, Maeve A. Hennessy, Wenji Guo, Rita Nanda

• April 23, 2026